喘儿童的语言下免疫疗法:一个基于人口的注册研究
Jon R Konradsen1,2,3, Cecilia Lundholm3, Anna M Hedman3
1Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
The journal of allergy and clinical immunology. Global
|November 5, 2025
概括
在患有喘的儿童中,较长时间的语言下免疫疗法 (SLIT) 改善了结果. 增加家长教育与较长的SLIT持续时间有关,这反过来又减少了不受控制的喘症状.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 现实世界 证据研究 实证研究
背景情况:
- 已知三年内每天服用的舌下免疫疗法 (SLIT) 可以减少过敏疾病症状并诱导耐受性.
- 关于喘儿童接受SLIT的现实世界数据有限.
研究的目的:
- 为了描述患有喘的儿童的特征,他开出了SLIT.
- 在现实世界中分析SLIT持续时间及其对喘发病率的影响.
主要方法:
- 基于人口的研究,使用瑞典国家航空航道登记册 (SNAR) 和其他国家登记册.
- 包括1514名患有喘的儿童 (5-17岁) 处方SLIT,其中782人有SLIT后的数据.
- 提取的数据包括年龄,性别,喘控制测试成绩,螺旋计,SLIT发行记录和社会经济背景.
主要成果:
- 在男孩 (69%) 和青少年 (71%) 中,SLIT的患病率更高.
- 较高的家长教育与较长的SLIT持续时间 (≥4个月) 有关.
- 超过12个月的SLIT持续时间与不受控制的喘风险降低相关 (aOR=0.49).
结论:
- 在患有喘的儿童中,SLIT的延长时间与父母的高等教育有关.
- 较长时间的SLIT治疗与失控喘的可能性降低有关.
- 提高儿童喘患者的SLIT坚持的策略可能会产生显著的临床益处.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K


